Romesh Markus Selected Research

Romesh Markus Research Topics

14	Stroke (Strokes) 12/2020 - 01/2003
7	Ischemic Stroke 01/2019 - 01/2003
3	Cerebral Hemorrhage 01/2019 - 08/2013
3	Hypertension (High Blood Pressure) 08/2017 - 03/2011
3	Infarction (Infarctions) 01/2012 - 02/2004
2	Diabetes Mellitus 08/2017 - 02/2017
2	Atrial Fibrillation 02/2014 - 03/2011
2	Retinal Artery Occlusion 08/2011 - 02/2011
2	Ischemia 10/2005 - 11/2004
1	Brain Diseases (Brain Disorder) 12/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Cerebellar Ataxia (Dysmetria) 07/2017
1	Encephalitis (Encephalitis, Rasmussen) 07/2017
1	Exanthema (Rash) 07/2017
1	Inappropriate ADH Syndrome (SIADH) 07/2017
1	Infections 07/2017
1	Leukocytosis (Pleocytosis) 07/2017
1	Hematoma 06/2014
1	Hemorrhage 06/2014
1	Headache (Headaches) 12/2012
1	Left Ventricular Dysfunction 12/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2012
1	HIV Infections (HIV Infection) 08/2012
1	Thrombosis (Thrombus) 08/2011
1	Eye Pain 07/2011
1	Myocardial Infarction 02/2011
1	Inflammation (Inflammations) 01/2006
1	Brain Hypoxia (Cerebral Hypoxia) 02/2004

6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 10/2010
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 06/2015
2	Warfarin (Coumadin)FDA LinkGeneric 02/2014 - 08/2013
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 08/2013 - 10/2010
2	FibrinIBA 08/2011 - 02/2011
2	Neuroprotective AgentsIBA 01/2006 - 11/2004
1	Contrast MediaIBA 12/2020
1	GadoliniumIBA 12/2020
1	Vasopressins (Vasopressin)IBA 07/2017
1	Glucose (Dextrose)FDA LinkGeneric 07/2017
1	Biological ProductsIBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Tranexamic Acid (AMCA)FDA Link 06/2014
1	RivaroxabanIBA 02/2014
1	Vitamin K FDA Link 02/2014
1	SaltsIBA 07/2011
1	CholesterolIBA 03/2011
1	boldenone undecylenate (Equipoise)IBA 02/2011
1	Blood Glucose (Blood Sugar)IBA 10/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2006
1	fluoromisonidazoleIBA 02/2004
1	Flumazenil (Romazicon)FDA LinkGeneric 02/2004

5	Therapeutics 06/2014 - 01/2003
2	Percutaneous Coronary Intervention 08/2017 - 02/2017
2	Thrombolytic Therapy 01/2012 - 01/2003
1	Catheters 02/2014
1	Secondary Prevention 02/2014
1	Critical Care (Surgical Intensive Care) 12/2012
1	Highly Active Antiretroviral Therapy (HAART) 08/2012
1	Intravenous Infusions 02/2011